{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T12:38:08Z","timestamp":1782131888397,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T00:00:00Z","timestamp":1527638400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Pudong New Area Zhoupu Hospital College Key Discipline Construction Projects","award":["ZP-XK-2015B-5"],"award-info":[{"award-number":["ZP-XK-2015B-5"]}]},{"name":"Shanghai Pudong New Area Key Discipline Construction Projects","award":["PD-XK-2017A-9"],"award-info":[{"award-number":["PD-XK-2017A-9"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Res"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40659-018-0163-x","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T21:33:46Z","timestamp":1527629626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The NK1 receptor antagonist NKP608 inhibits proliferation of human colorectal cancer cells via Wnt signaling pathway"],"prefix":"10.1186","volume":"51","author":[{"given":"Xiao-Ling","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Feng","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,30]]},"reference":[{"issue":"141","key":"163_CR1","first-page":"1315","volume":"2008\u20132013","author":"R Pan","year":"2017","unstructured":"Pan R, Zhu M, Yu C, Lv J, Guo Y, Bian Z, et al. Cancer incidence and mortality: a cohort study in China. 2017;2008\u20132013(141):1315\u201323.","journal-title":"Cancer incidence and mortality: a cohort study in China"},{"key":"163_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/j.seminoncol.2017.02.002","volume":"44","author":"Y Choi","year":"2017","unstructured":"Choi Y, Sateia HF, Peairs KS, Stewart RW. Screening for colorectal cancer. Semin Oncol. 2017;44:34\u201344.","journal-title":"Semin Oncol"},{"key":"163_CR3","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMra1513581","volume":"374","author":"WB Strum","year":"2016","unstructured":"Strum WB. Colorectal adenomas. N Engl J Med. 2016;374:1065\u201375.","journal-title":"N Engl J Med"},{"key":"163_CR4","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/cncr.30080","volume":"122","author":"JT Lowery","year":"2016","unstructured":"Lowery JT, Ahnen DJ, Schroy PC III, Hampel H, Baxter N, Boland CR, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. 2016;122:2633\u201345.","journal-title":"Cancer"},{"key":"163_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s10620-015-3979-z","volume":"61","author":"N Sengupta","year":"2016","unstructured":"Sengupta N, Yee E, Feuerstein JD. Colorectal cancer screening in inflammatory bowel disease. Dig Dis Sci. 2016;61:980\u20139.","journal-title":"Dig Dis Sci"},{"key":"163_CR6","doi-asserted-by":"crossref","unstructured":"Lieberman DA, Williams JL, Holub JL, Morris CD, Logan JR, Eisen GM, et al. Race, ethnicity, and sex affect risk for polyps\u2009>\u20099\u00a0mm in average-risk individuals. Gastroenterology 2014;147:351\u20138; quiz e14\u20135.","DOI":"10.1053\/j.gastro.2014.04.037"},{"key":"163_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0166-4328(02)00024-4","volume":"133","author":"C Gentsch","year":"2002","unstructured":"Gentsch C, Cutler M, Vassout A, Veenstra S, Brugger F. Anxiolytic effect of NKP608, a NK1-receptor antagonist, in the social investigation test in gerbils. Behav Brain Res. 2002;133:363\u20138.","journal-title":"Behav Brain Res"},{"key":"163_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0166-4328(00)00230-8","volume":"115","author":"M Papp","year":"2000","unstructured":"Papp M, Vassout A, Gentsch C. The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats. Behav Brain Res. 2000;115:19\u201323.","journal-title":"Behav Brain Res"},{"key":"163_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jhep.2013.12.024","volume":"60","author":"M Berger","year":"2014","unstructured":"Berger M, Neth O, Ilmer M, Garnier A, Salinas-Martin MV, de Agustin Asencio JC, et al. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo. J Hepatol. 2014;60:985\u201394.","journal-title":"J Hepatol"},{"key":"163_CR10","first-page":"421","volume":"66","author":"M Munoz","year":"2015","unstructured":"Munoz M, Recio S, Rosso M, Redondo M, Covenas R. The antiproliferative action of [d-Arg(1), d-Phe(5), d-Trp(7,9), LEU(11)] substance P analogue antagonist against small-cell- and non-small-cell lung cancer cells could be due to the pharmacological profile of its tachykinin receptor antagonist. J Physiol Pharmacol Off J Pol Physiol Soc. 2015;66:421\u20136.","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc."},{"key":"163_CR11","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.3390\/cancers7030832","volume":"7","author":"M Munoz","year":"2015","unstructured":"Munoz M, Covenas R. Targeting NK-1 receptors to prevent and treat pancreatic cancer: a new therapeutic approach. Cancers (Basel). 2015;7:1215\u201332.","journal-title":"Cancers (Basel)"},{"key":"163_CR12","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.pharep.2017.02.002","volume":"69","author":"M Munoz","year":"2017","unstructured":"Munoz M, Rosso M, Covenas R. The NK-1 receptor antagonist L-732,138 induces apoptosis in human gastrointestinal cancer cell lines. Pharmacol Rep. 2017;69:696\u2013701.","journal-title":"Pharmacol Rep."},{"key":"163_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.peptides.2014.01.030","volume":"55","author":"A Gonzalez-Ortega","year":"2014","unstructured":"Gonzalez-Ortega A, Sanchez-Vaderrabanos E, Ramiro-Fuentes S, Salinas-Martin MV, Carranza A, Covenas R, et al. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor. Peptides. 2014;55:1\u201312.","journal-title":"Peptides"},{"key":"163_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.gene.2015.02.002","volume":"560","author":"J Dong","year":"2015","unstructured":"Dong J, Feng F, Xu G, Zhang H, Hong L, Yang J. Elevated SP\/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration. Gene. 2015;560:205\u201310.","journal-title":"Gene"},{"key":"163_CR15","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12038-015-9530-8","volume":"40","author":"M Munoz","year":"2015","unstructured":"Munoz M, Covenas R, Esteban F, Redondo M. The substance P\/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs. J Biosci. 2015;40:441\u201363.","journal-title":"J Biosci"},{"key":"163_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10637-009-9218-8","volume":"28","author":"M Munoz","year":"2010","unstructured":"Munoz M, Rosso M. The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug. Investig N Drugs. 2010;28:187\u201393.","journal-title":"Investig N Drugs"},{"key":"163_CR17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3390\/cancers2020611","volume":"2","author":"M Munoz","year":"2010","unstructured":"Munoz M, Rosso M, Gonzalez-Ortega A, Covenas R. The NK-1 receptor antagonist L-732,138 induces apoptosis and counteracts substance P-related mitogenesis in human melanoma cell lines. Cancers (Basel). 2010;2:611\u201323.","journal-title":"Cancers (Basel)"},{"key":"163_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"The Cancer Genome Atlas Network","year":"2012","unstructured":"The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330\u20137.","journal-title":"Nature"},{"key":"163_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","volume":"17","author":"BT MacDonald","year":"2009","unstructured":"MacDonald BT, Tamai K, He X. Wnt\/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17:9\u201326.","journal-title":"Dev Cell"},{"key":"163_CR20","doi-asserted-by":"crossref","unstructured":"Behrens J. Control of beta-catenin signaling in tumor development. Ann NY Acad Sci. 2000;910:21\u201333; discussion 33\u20135.","DOI":"10.1111\/j.1749-6632.2000.tb06698.x"},{"key":"163_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3892\/ijo.2015.3016","volume":"47","author":"A Garnier","year":"2015","unstructured":"Garnier A, Vykoukal J, Hubertus J, Alt E, von Schweinitz D, Kappler R, et al. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells. Int J Oncol. 2015;47:151\u201360.","journal-title":"Int J Oncol"},{"key":"163_CR22","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1517\/14728222.2011.586633","volume":"15","author":"M Munoz","year":"2011","unstructured":"Munoz M, Bernabeu-Wittel J, Covenas R. NK-1 as a melanoma target. Expert Opin Ther Targets. 2011;15:889\u201397.","journal-title":"Expert Opin Ther Targets"},{"key":"163_CR23","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H. Wnt\/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell. 2017;169:985\u201399.","journal-title":"Cell"},{"key":"163_CR24","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.7150\/jca.18560","volume":"8","author":"J Xu","year":"2017","unstructured":"Xu J, Lv W, Hu Y, Wang L, Wang Y, Cao J, et al. Wnt3a expression is associated with epithelial\u2013mesenchymal transition and impacts prognosis of lung adenocarcinoma patients. J Cancer. 2017;8:2523\u201331.","journal-title":"J Cancer"},{"key":"163_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13046-014-0107-4","volume":"33","author":"L Qi","year":"2014","unstructured":"Qi L, Sun B, Liu Z, Cheng R, Li Y, Zhao X. Wnt3a expression is associated with epithelial\u2013mesenchymal transition and promotes colon cancer progression. J Exp Clin cancer Res CR. 2014;33:107.","journal-title":"J Exp Clin cancer Res CR"},{"key":"163_CR26","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.3748\/wjg.v22.i14.3829","volume":"22","author":"LH Pan","year":"2016","unstructured":"Pan LH, Yao M, Cai Y, Gu JJ, Yang XL, Wang L, et al. Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma. World J Gastroenterol. 2016;22:3829\u201336.","journal-title":"World J Gastroenterol"},{"key":"163_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bcp.2012.08.011","volume":"84","author":"HJ Chen","year":"2012","unstructured":"Chen HJ, Hsu LS, Shia YT, Lin MW, Lin CM. The beta-catenin\/TCF complex as a novel target of resveratrol in the Wnt\/beta-catenin signaling pathway. Biochem Pharmacol. 2012;84:1143\u201353.","journal-title":"Biochem Pharmacol"},{"key":"163_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/labinvest.3700158","volume":"84","author":"H Laux","year":"2004","unstructured":"Laux H, Tomer R, Mader MT, Smida J, Budczies J, Kappler R, et al. Tumor-associated E-cadherin mutations do not induce Wnt target gene expression, but affect E-cadherin repressors. Lab Investig. 2004;84:1372\u201386.","journal-title":"Lab Investig."},{"key":"163_CR29","doi-asserted-by":"publisher","first-page":"a002915","DOI":"10.1101\/cshperspect.a002915","volume":"2","author":"J Heuberger","year":"2010","unstructured":"Heuberger J, Birchmeier W. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol. 2010;2:a002915.","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"163_CR30","first-page":"263","volume":"3","author":"MJ Pishvaian","year":"2007","unstructured":"Pishvaian MJ, Byers SW. Biomarkers of WNT signaling. Cancer Biomark Sect A Dis Markers. 2007;3:263\u201374.","journal-title":"Cancer Biomark Sect A Dis Markers"},{"key":"163_CR31","first-page":"3145","volume":"63","author":"V Easwaran","year":"2003","unstructured":"Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, et al. Beta-catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 2003;63:3145\u201353.","journal-title":"Cancer Res"},{"key":"163_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.4251\/wjgo.v8.i8.583","volume":"8","author":"AM Abraha","year":"2016","unstructured":"Abraha AM, Ketema EB. Apoptotic pathways as a therapeutic target for colorectal cancer treatment. World J Gastrointest Oncol. 2016;8:583\u201391.","journal-title":"World J Gastrointest Oncol."},{"key":"163_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0167-0115(00)00194-4","volume":"96","author":"A Vassout","year":"2000","unstructured":"Vassout A, Veenstra S, Hauser K, Ofner S, Brugger F, Schilling W, et al. NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regul Pept. 2000;96:7\u201316.","journal-title":"Regul Pept"}],"container-title":["Biological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-018-0163-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40659-018-0163-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40659-018-0163-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T19:13:55Z","timestamp":1559157235000},"score":1,"resource":{"primary":{"URL":"https:\/\/biolres.biomedcentral.com\/articles\/10.1186\/s40659-018-0163-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["163"],"URL":"https:\/\/doi.org\/10.1186\/s40659-018-0163-x","relation":{},"ISSN":["0717-6287"],"issn-type":[{"value":"0717-6287","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,30]]},"assertion":[{"value":"18 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}